[18F]PARPi Imaging Is Not Affected by HPV Status In Vitro

Background. Human papillomavirus- (HPV-) associated oropharyngeal squamous cell carcinomas (OPSCCs) are clinically and pathologically distinct from HPV-negative tumors. Here, we explore whether HPV affects functional biomarkers, including γH2AX, RAD51, and PARP1. Moreover, the role of [18F]PARPi as...

Full description

Saved in:
Bibliographic Details
Main Authors: Navjot Guru, Paula Demétrio De Souza França, Giacomo Pirovano, Cien Huang, Snehal G. Patel, Thomas Reiner
Format: Article
Language:English
Published: SAGE Publishing 2021-01-01
Series:Molecular Imaging
Online Access:http://dx.doi.org/10.1155/2021/6641397
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561843003293696
author Navjot Guru
Paula Demétrio De Souza França
Giacomo Pirovano
Cien Huang
Snehal G. Patel
Thomas Reiner
author_facet Navjot Guru
Paula Demétrio De Souza França
Giacomo Pirovano
Cien Huang
Snehal G. Patel
Thomas Reiner
author_sort Navjot Guru
collection DOAJ
description Background. Human papillomavirus- (HPV-) associated oropharyngeal squamous cell carcinomas (OPSCCs) are clinically and pathologically distinct from HPV-negative tumors. Here, we explore whether HPV affects functional biomarkers, including γH2AX, RAD51, and PARP1. Moreover, the role of [18F]PARPi as a broadly applicable imaging tool for head and neck carcinomas is investigated. Methods. HPV-positive and HPV-negative cell lines were used to evaluate the γH2AX, RAD51, and PARP1 expression with immunoblotting and immunofluorescence. Effects of external beam ionizing radiation were investigated in vitro, and survival was investigated via colony-formation assay. [18F]PARPi uptake experiments were performed on HPV-negative and HPV-positive cell lines to quantify PARP1 expression. PARP1 IHC and γH2AX foci were quantified using patient-derived oropharyngeal tumor specimens. Results. Differences in DNA repair were detected, showing higher RAD51 and γH2AX expression in HPV-positive cell lines. Clonogenic assays confirm HPV-positive cell lines to be significantly more radiosensitive. PARP1 expression levels were similar, irrespective of HPV status. Consequently, [18F]PARPi uptake assays demonstrated that this tracer is internalized in cell lines independently from their HPV status. Conclusion. The HPV status, often used clinically to stratify patients, did not affect PARP1 levels, suggesting that PARP imaging can be performed in both HPV-positive and HPV-negative patients. This study confirms that the PET imaging agent [18F]PARPi could serve as a general clinical tool for oropharyngeal cancer patients.
format Article
id doaj-art-345caf3642574dcd81c2a0e72746fd77
institution Kabale University
issn 1536-0121
language English
publishDate 2021-01-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-345caf3642574dcd81c2a0e72746fd772025-01-03T01:22:57ZengSAGE PublishingMolecular Imaging1536-01212021-01-01202110.1155/2021/66413976641397[18F]PARPi Imaging Is Not Affected by HPV Status In VitroNavjot Guru0Paula Demétrio De Souza França1Giacomo Pirovano2Cien Huang3Snehal G. Patel4Thomas Reiner5Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USADepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USADepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USADepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USADepartment of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USADepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USABackground. Human papillomavirus- (HPV-) associated oropharyngeal squamous cell carcinomas (OPSCCs) are clinically and pathologically distinct from HPV-negative tumors. Here, we explore whether HPV affects functional biomarkers, including γH2AX, RAD51, and PARP1. Moreover, the role of [18F]PARPi as a broadly applicable imaging tool for head and neck carcinomas is investigated. Methods. HPV-positive and HPV-negative cell lines were used to evaluate the γH2AX, RAD51, and PARP1 expression with immunoblotting and immunofluorescence. Effects of external beam ionizing radiation were investigated in vitro, and survival was investigated via colony-formation assay. [18F]PARPi uptake experiments were performed on HPV-negative and HPV-positive cell lines to quantify PARP1 expression. PARP1 IHC and γH2AX foci were quantified using patient-derived oropharyngeal tumor specimens. Results. Differences in DNA repair were detected, showing higher RAD51 and γH2AX expression in HPV-positive cell lines. Clonogenic assays confirm HPV-positive cell lines to be significantly more radiosensitive. PARP1 expression levels were similar, irrespective of HPV status. Consequently, [18F]PARPi uptake assays demonstrated that this tracer is internalized in cell lines independently from their HPV status. Conclusion. The HPV status, often used clinically to stratify patients, did not affect PARP1 levels, suggesting that PARP imaging can be performed in both HPV-positive and HPV-negative patients. This study confirms that the PET imaging agent [18F]PARPi could serve as a general clinical tool for oropharyngeal cancer patients.http://dx.doi.org/10.1155/2021/6641397
spellingShingle Navjot Guru
Paula Demétrio De Souza França
Giacomo Pirovano
Cien Huang
Snehal G. Patel
Thomas Reiner
[18F]PARPi Imaging Is Not Affected by HPV Status In Vitro
Molecular Imaging
title [18F]PARPi Imaging Is Not Affected by HPV Status In Vitro
title_full [18F]PARPi Imaging Is Not Affected by HPV Status In Vitro
title_fullStr [18F]PARPi Imaging Is Not Affected by HPV Status In Vitro
title_full_unstemmed [18F]PARPi Imaging Is Not Affected by HPV Status In Vitro
title_short [18F]PARPi Imaging Is Not Affected by HPV Status In Vitro
title_sort 18f parpi imaging is not affected by hpv status in vitro
url http://dx.doi.org/10.1155/2021/6641397
work_keys_str_mv AT navjotguru 18fparpiimagingisnotaffectedbyhpvstatusinvitro
AT paulademetriodesouzafranca 18fparpiimagingisnotaffectedbyhpvstatusinvitro
AT giacomopirovano 18fparpiimagingisnotaffectedbyhpvstatusinvitro
AT cienhuang 18fparpiimagingisnotaffectedbyhpvstatusinvitro
AT snehalgpatel 18fparpiimagingisnotaffectedbyhpvstatusinvitro
AT thomasreiner 18fparpiimagingisnotaffectedbyhpvstatusinvitro